Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

4
Judge tosses NYC's climate change lawsuit against 5 big oil companies

2m cnbc
A federal judge on Thursday threw out a lawsuit brought by New York City against five major oil companies for their role in contributing to climate change.
RDS.B RDS.A XOM RYDBF RDSB RDSA RYDAF

7
New York's Global Warming Suit Against Oil Companies Tossed - Bloomberg

27m bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
RDS.B RDS.A XOM BP RDSB RDSA BP.A BP.B BP CVX RYDBF BPAQF RYDAF

1
LNG terminal poised to boost struggling Canadian gas producers

1h worldoil
TORONTO (Bloomberg) -- A liquefied natural gas terminal in British Columbia will “re-focus people on Canadian gas,” giving a boost to stocks like Tourmaline Oil and ARC Resources, according to the manager of more than C$500 million ($377 million) in assets for Bank of Nova Scotia.
AETUF RDS.B RDS.A RDSB RDSA ARX SU TOU CNQ CVX RYDBF TRMLF RYDAF SU

2
Market report: WPP shares near five-year low after sales dip at major rival

1h telegraph.co.uk
Leaderless ad giant WPP slid back towards a five-year low after a surprise sales dip at French rival Publicis reignited fears over the impact of the EU’s new data protection laws and the sector shake-up caused by Silicon Valley giants.
RDS.B RDS.A RYDBF URI RDSB RDSA RYDAF

1
UPDATE 1-Mexico shelves oil auctions until after leftist leader takes office

2018-07-18 reuters
MEXICO CITY (Reuters) - Mexican oil auctions originally set for later this year will be postponed until February, Mexico’s oil regulator announced on Wednesday, allowing time for leftist President-elect Andres Manuel Lopez Obrador to take office.
RDS.B RDS.A RYDBF RDSB RDSA RYDAF

1
Brazil M&A seen slowing in run-up to presidential election

2018-07-18 reuters
SAO PAULO (Reuters) - Bankers and lawyers expect the pipeline of big deals in Brazil to shrink in coming months as financial and strategic acquirers avoid taking risks due to market volatility during a presidential campaign and doubts about the economy’s recovery.
RDS.B RDS.A KROTY VALE3 LYB MS.PRE KROTF MS.PRF MS.PRG RDSB RDSA MS.PRA CZZ MS.PRI MS.PRK LALWF RYDBF MS RYDAF

7
Is This The End Of The Oil Rally?

2018-07-17 oilprice
Tom majored in International Business at Amsterdam’s Higher School of Economics, he is now working as news editor for Oilprice.com.
TRP RDS.B RDS.A XOM RYDBF ICE RDSB RDSA RYDAF PAA

1
Shell Lifts Force Majeure On Nigeria’s Bonny Light Oil Exports

2018-07-17 oilprice
Tsvetana is a writer for the U.S.-based Divergente LLC consulting firm with over a decade of experience writing for news outlets such as iNVEZZ and…
RDS.B RDS.A RYDBF RDSB RDSA RYDAF

1
Trump says U.S. will compete with Russia for European gas market

2018-07-16 worldoil
MOSCOW (Bloomberg) -- U.S. President Donald Trump eased his tone about a Russian natural gas pipeline to Germany after a one-on-one meeting with President Vladimir Putin, shifting from the harsh criticism he’d levied in Europe last week.
RDS.B RDS.A UNPPY OMVKY RDSB RDSA UNPRF OMVJF ENGI OMVZY RYDBF BFFAF BFA BASFY RYDAF

1
Trump: US to Compete With Russia for Europe Gas Market

2018-07-16 rigzone
(Bloomberg) -- U.S. President Donald Trump eased his tone about a Russian natural gas pipeline to Germany after a one-on-one meeting with President Vladimir Putin, shifting from the harsh criticism he’d levied in Europe last week.
RDS.B RDS.A UNPPY OMVKY RDSB RDSA UNPRF OMVJF ENGI OMVZY RYDBF BFFAF BFA BASFY RYDAF

1
Market report: Fears of supply surge send oil giants BP and Shell tumbling

2018-07-16 telegraph.co.uk
Oil giants BP and Shell dragged the FTSE 100 lower after a sharp slide in crude prices caused by traders bracing for a supply surge that may end a year-long rally.
RDS.B RDS.A RGORF RYDBF GOG RDSB GOLD RDSA RYDAF RRS GOLD

1
Norway oil strike escalates with limited supply impact

2018-07-16 worldoil
OSLO (Bloomberg) -- Norwegian drilling workers escalated a strike early Monday, with the impact on the country’s oil production expected to remain limited to one North Sea field in the short term.
RDS.B RDS.A RYDBF RDSB RDSA RYDAF

1
UPDATE 1-UK Stocks-Factors to watch on July 16

2018-07-16 reuters
July 16 (Reuters) - Britain’s FTSE 100 futures were flat ahead of the cash market open on Monday.
RDS.B RDS.A RYDBF RDSB RDSA RYDAF

5
Canada's US$30b LNG hope edges closer as Shell ramps up

2018-07-15 theedgemarkets
VANCOUVER (July 15): A flurry of activity in a remote Canadian town is raising optimism that Royal Dutch Shell Plc and its partners are ready to go ahead with the nation’s largest infrastructure project: a C$40 billion liquefied natural gas (LNG) terminal that could at last unlock energy exports to Asia.
APC BCS OIL RIO RIO KMI.WS RDSB RDSA 83SF RTPPF 83SK KMI.PRA KMI RTNTF RYDAF KMR CVB 47MC FP TRP RDS.B RDS.A RIO RYDBF AEUA KMRFZ

4
STOXX 600 18Q2 Earnings Preview - Where Is The Growth Coming From?

2018-07-14 seekingalpha
Surprised to learn that 5 companies are responsible for driving 67% of the overall 18Q2 STOXX 600 EPS growth rate? Read on...
FP E RDS.B BP RDS.A RYDBF RDSB TOT RDSA RYDAF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: G7690A118